(VIANEWS) – The Market ended the session with NYXOAH (NYXH.BR) rising 13.74% to €4.80 on Tuesday, after two successive sessions in a row of gains. BEL 20 jumped 0.16% to €3,598.54, after two successive sessions in a row of gains, on what was a somewhat positive trend trading session today.
NYXOAH’s last close was €4.22, 54.43% under its 52-week high of €9.26.
About NYXOAH
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-1.68.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.76%.
Sales Growth
NYXOAH’s sales growth is 11.7% for the current quarter and 25.6% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
NYXOAH’s EBITDA is -13.74.
More news about NYXOAH (NYXH.BR).
